Identifying novel host-based diagnostic biomarker panels for COVID-19: a whole-blood/nasopharyngeal transcriptome meta-analysis

Table 1 The number of WB and NP samples applied in this study

Tissue	GSE^a	COVID-19	HC	Not-COVID	Other respiratory diseases	Refs
WB	163,151	7	20			Ng et al. (2021)
WB	151,161	39				–
WB	152,641	62	24			Thair et al. (2020a)
WB	169,687		14			–
WB	172,450		13			–
NP	152,075	430		54		Lieberman et al. (2020)
NP	156,063	93			Other viruses = 41, non-viral = 100	Mick et al. (2020)
NP	163,151	138	11		Influenza = 76^b, other Corona viruses = 12^b, other viruses = 32, non-viral = 82	Ng et al. (2021)
NP	188,678	90			other viruses = 59, non-viral = 169	–

^aGenomic Spatial Event (GSE) database (Danford et al. 2008)
^bThe samples related to “Influenza” and “other corona” were labeled as other viruses in the analysis

ISSN: 1528-3658